p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast
- PMID: 12461063
- PMCID: PMC1769826
- DOI: 10.1136/jcp.55.12.936
p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast
Abstract
Aims: One of the limitations of fine needle aspiration biopsy (FNAB) of the breast is in distinguishing invasive carcinoma (IDC) from ductal carcinoma in situ (DCIS). It has been proposed that the presence of myoepithelial cells overlying epithelial malignant cell clusters suggests DCIS. However, the recognition of myoepithelial cells in aspirates may be difficult. The aim of this study was to investigate a new nuclear myoepithelial cell marker, p63, a p53 homologue nuclear transcription factor, in a series of breast FNABs in an attempt to distinguish IDC from DCIS.
Methods: Papanicolaou stained smears from eight cases of pure DCIS and 15 cases of pure IDC with a histologically confirmed diagnosis were submitted to immunocytochemical analysis using the antibody 4A4 against p63. Two pathologists evaluated the presence of p63 positive cells overlying malignant cell clusters and admixed with malignant cells. The frequency of p63 positive cells in DCIS and IDC was compared using Fisher's exact test.
Results: p63 consistently stained the nuclei of myoepithelial cells, either overlying malignant cell clusters and/or admixed with malignant cells. p63 positive myoepithelial cells were seen in all DCIS cases and in nine of the 15 cases of IDC (p = 0.0375). In eight cases (three DCIS and five IDC), scattered p63+ epithelial malignant cells were seen.
Conclusions: Although p63 positive myoepithelial cells are found more frequently in DCIS cases, their presence cannot be used as a criterion to rule out invasion in breast FNABs because they are present in up to 60% of invasive cases.
Figures


Similar articles
-
Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.Cancer. 2003 Jun 25;99(3):172-9. doi: 10.1002/cncr.11061. Cancer. 2003. PMID: 12811858
-
Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.Am J Surg Pathol. 2003 Jan;27(1):82-90. doi: 10.1097/00000478-200301000-00009. Am J Surg Pathol. 2003. PMID: 12502930
-
Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.Clin Breast Cancer. 2015 Oct;15(5):335-42. doi: 10.1016/j.clbc.2015.01.004. Epub 2015 Jan 21. Clin Breast Cancer. 2015. PMID: 25700939
-
Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.Hum Pathol. 2016 Mar;49:114-23. doi: 10.1016/j.humpath.2015.11.003. Epub 2015 Nov 17. Hum Pathol. 2016. PMID: 26826418 Review.
-
Molecular markers for the diagnosis and management of ductal carcinoma in situ.J Natl Cancer Inst Monogr. 2010;2010(41):210-3. doi: 10.1093/jncimonographs/lgq019. J Natl Cancer Inst Monogr. 2010. PMID: 20956832 Free PMC article. Review.
Cited by
-
c-KIT and PDGFRA in breast phyllodes tumours: overexpression without mutations?J Clin Pathol. 2004 Oct;57(10):1075-9. doi: 10.1136/jcp.2004.016378. J Clin Pathol. 2004. PMID: 15452163 Free PMC article.
-
Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging.Antioxidants (Basel). 2023 Jan 20;12(2):240. doi: 10.3390/antiox12020240. Antioxidants (Basel). 2023. PMID: 36829799 Free PMC article.
-
The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.J Clin Pathol. 2007 Mar;60(3):315-20. doi: 10.1136/jcp.2006.036830. Epub 2006 May 12. J Clin Pathol. 2007. PMID: 16698948 Free PMC article.
-
Study of the Immunohistochemical Expression of p63 in Benign Lesions and Carcinoma of the Breast at a Tertiary Hospital in South India.Cureus. 2023 Nov 9;15(11):e48557. doi: 10.7759/cureus.48557. eCollection 2023 Nov. Cureus. 2023. PMID: 38024052 Free PMC article.
-
Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.Virchows Arch. 2003 Aug;443(2):122-32. doi: 10.1007/s00428-003-0859-2. Epub 2003 Jul 16. Virchows Arch. 2003. PMID: 12884041
References
-
- McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: invasive vs. in situ carcinoma. Diagn Cytopathol 2001;25:73–7. - PubMed
-
- Bondeson L, Lindholm K. Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 1997;17:315–20. - PubMed
-
- Symmans WF, Cangiarella JF, Gottlieb S, et al. What is the role of cytopathologists in stereotaxic needle biopsy diagnosis of nonpalpable mammographic abnormalities? Diagn Cytopathol 2001;24:260–70. - PubMed
-
- Westenend PJ, Sever AR, Beekman-De Volder HJ, et al. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer 2001;93:146–50. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous